Clinical-stage biotechnology company Anixa Biosciences, Inc. (ANIX) announced Tuesday that its collaborator, Cleveland Clinic, has received a Japanese Patent for Ovarian Cancer Vaccine technology.
Sharjah research edges closer to powerful new targeted cancer therapy thenationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationalnews.com Daily Mail and Mail on Sunday newspapers.
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
Scientists are currently testing a vaccine that could prevent the reoccurrence of triple-negative breast cancer, the most aggressive form of the disease.